| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 182 | 2024 | 5033 | 4.670 |
Why?
|
| Cardiomyopathy, Hypertrophic | 45 | 2023 | 1337 | 3.560 |
Why?
|
| Heart Ventricles | 95 | 2023 | 3831 | 3.310 |
Why?
|
| Cardiomyopathy, Dilated | 42 | 2024 | 844 | 3.290 |
Why?
|
| Heart Defects, Congenital | 97 | 2024 | 4712 | 2.980 |
Why?
|
| Ventricular Function, Left | 85 | 2024 | 3925 | 2.900 |
Why?
|
| Myocardial Contraction | 62 | 2020 | 1516 | 2.780 |
Why?
|
| Ventricular Dysfunction, Left | 45 | 2020 | 2136 | 2.450 |
Why?
|
| Aortic Valve Insufficiency | 23 | 2023 | 575 | 2.370 |
Why?
|
| Echocardiography, Doppler | 38 | 2024 | 899 | 2.310 |
Why?
|
| Heart | 45 | 2023 | 4416 | 1.800 |
Why?
|
| Cardiomyopathies | 27 | 2024 | 2060 | 1.650 |
Why?
|
| Sarcomeres | 15 | 2020 | 379 | 1.600 |
Why?
|
| Heart Transplantation | 36 | 2022 | 3301 | 1.440 |
Why?
|
| Transposition of Great Vessels | 27 | 2023 | 581 | 1.390 |
Why?
|
| Aortic Valve Stenosis | 31 | 2020 | 2021 | 1.330 |
Why?
|
| Infant | 216 | 2023 | 36424 | 1.310 |
Why?
|
| Hypertrophy, Left Ventricular | 24 | 2023 | 855 | 1.310 |
Why?
|
| Child, Preschool | 221 | 2023 | 42509 | 1.300 |
Why?
|
| Ventricular Remodeling | 22 | 2024 | 1276 | 1.270 |
Why?
|
| Child | 273 | 2024 | 80567 | 1.250 |
Why?
|
| Cardiac Surgical Procedures | 34 | 2023 | 3681 | 1.220 |
Why?
|
| Antibiotics, Antineoplastic | 11 | 2023 | 678 | 1.180 |
Why?
|
| Doxorubicin | 16 | 2023 | 2226 | 1.170 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 15 | 2015 | 538 | 1.060 |
Why?
|
| Diastole | 28 | 2022 | 785 | 1.040 |
Why?
|
| Fontan Procedure | 20 | 2018 | 805 | 1.010 |
Why?
|
| Heart Septal Defects, Ventricular | 21 | 2023 | 477 | 0.950 |
Why?
|
| Infant, Newborn | 140 | 2023 | 26379 | 0.930 |
Why?
|
| Adolescent | 198 | 2023 | 88808 | 0.890 |
Why?
|
| Body Surface Area | 8 | 2021 | 206 | 0.870 |
Why?
|
| Heart Valve Diseases | 10 | 2023 | 1029 | 0.830 |
Why?
|
| Registries | 40 | 2024 | 8343 | 0.830 |
Why?
|
| Heart Atria | 15 | 2023 | 1363 | 0.810 |
Why?
|
| Aortic Diseases | 9 | 2023 | 741 | 0.800 |
Why?
|
| Hypoplastic Left Heart Syndrome | 13 | 2014 | 595 | 0.790 |
Why?
|
| Heart Diseases | 20 | 2024 | 2817 | 0.780 |
Why?
|
| Stroke Volume | 49 | 2024 | 5590 | 0.760 |
Why?
|
| Mitral Valve Insufficiency | 12 | 2023 | 1414 | 0.740 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 13 | 2023 | 1559 | 0.730 |
Why?
|
| Heart Failure | 30 | 2024 | 11815 | 0.700 |
Why?
|
| Heart Bypass, Right | 7 | 2017 | 75 | 0.670 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 3 | 2018 | 22 | 0.670 |
Why?
|
| Magnetic Resonance Imaging, Cine | 15 | 2023 | 1093 | 0.670 |
Why?
|
| Cardiac Volume | 9 | 2018 | 196 | 0.660 |
Why?
|
| Aortic Coarctation | 11 | 2013 | 278 | 0.650 |
Why?
|
| Death, Sudden, Cardiac | 11 | 2022 | 1566 | 0.650 |
Why?
|
| Ventricular Function | 17 | 2017 | 403 | 0.650 |
Why?
|
| Humans | 469 | 2024 | 766000 | 0.650 |
Why?
|
| Ventricular Outflow Obstruction | 10 | 2020 | 262 | 0.640 |
Why?
|
| Pulmonary Artery | 19 | 2013 | 1938 | 0.630 |
Why?
|
| Postoperative Complications | 40 | 2021 | 15803 | 0.620 |
Why?
|
| Hemodynamics | 35 | 2015 | 4188 | 0.620 |
Why?
|
| Heart Septal Defects, Atrial | 9 | 2022 | 452 | 0.610 |
Why?
|
| Anti-Retroviral Agents | 4 | 2020 | 1786 | 0.610 |
Why?
|
| Male | 281 | 2024 | 363855 | 0.610 |
Why?
|
| Echocardiography, Three-Dimensional | 7 | 2018 | 611 | 0.600 |
Why?
|
| Adrenergic beta-Antagonists | 11 | 2018 | 1237 | 0.600 |
Why?
|
| American Heart Association | 4 | 2023 | 1045 | 0.600 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2020 | 453 | 0.590 |
Why?
|
| Female | 293 | 2024 | 396158 | 0.580 |
Why?
|
| Myocardium | 24 | 2023 | 4765 | 0.570 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 6 | 2020 | 428 | 0.570 |
Why?
|
| Pulmonary Valve Stenosis | 6 | 2023 | 164 | 0.570 |
Why?
|
| Terminology as Topic | 12 | 2018 | 1536 | 0.560 |
Why?
|
| Dilatation, Pathologic | 18 | 2023 | 527 | 0.560 |
Why?
|
| Arrhythmias, Cardiac | 15 | 2020 | 2255 | 0.550 |
Why?
|
| Pulmonary Atresia | 5 | 2023 | 159 | 0.540 |
Why?
|
| Tricuspid Valve Insufficiency | 4 | 2020 | 361 | 0.540 |
Why?
|
| Systole | 25 | 2019 | 935 | 0.540 |
Why?
|
| Atenolol | 5 | 2020 | 99 | 0.530 |
Why?
|
| Cardiomyopathy, Restrictive | 4 | 2023 | 61 | 0.530 |
Why?
|
| Pregnancy Complications, Infectious | 7 | 2020 | 2184 | 0.520 |
Why?
|
| Razoxane | 3 | 2012 | 43 | 0.520 |
Why?
|
| Norwood Procedures | 6 | 2016 | 192 | 0.510 |
Why?
|
| Pediatrics | 20 | 2021 | 3609 | 0.510 |
Why?
|
| Cardiac Myosins | 5 | 2020 | 128 | 0.500 |
Why?
|
| Anthracyclines | 7 | 2024 | 285 | 0.490 |
Why?
|
| Catheterization | 9 | 2010 | 1426 | 0.490 |
Why?
|
| Body Height | 5 | 2021 | 1561 | 0.490 |
Why?
|
| Follow-Up Studies | 81 | 2023 | 39233 | 0.480 |
Why?
|
| Cardiomegaly | 12 | 2021 | 590 | 0.480 |
Why?
|
| Retrospective Studies | 107 | 2023 | 81542 | 0.480 |
Why?
|
| Iron Overload | 4 | 2023 | 245 | 0.480 |
Why?
|
| HIV Infections | 28 | 2020 | 17535 | 0.480 |
Why?
|
| Losartan | 5 | 2020 | 263 | 0.480 |
Why?
|
| Body Size | 3 | 2022 | 460 | 0.480 |
Why?
|
| Cardiology | 9 | 2024 | 1694 | 0.470 |
Why?
|
| Myosin Heavy Chains | 5 | 2020 | 403 | 0.460 |
Why?
|
| Aortic Valve | 13 | 2018 | 1964 | 0.460 |
Why?
|
| Enalapril | 4 | 2019 | 317 | 0.450 |
Why?
|
| Young Adult | 72 | 2024 | 59857 | 0.450 |
Why?
|
| Mitral Valve | 10 | 2023 | 1474 | 0.430 |
Why?
|
| Prospective Studies | 76 | 2023 | 54797 | 0.430 |
Why?
|
| Aorta, Thoracic | 9 | 2023 | 1109 | 0.420 |
Why?
|
| Atrial Function, Left | 3 | 2017 | 189 | 0.420 |
Why?
|
| Treatment Outcome | 88 | 2024 | 65199 | 0.420 |
Why?
|
| Coronary Vessels | 14 | 2013 | 3093 | 0.420 |
Why?
|
| Models, Cardiovascular | 6 | 2015 | 978 | 0.410 |
Why?
|
| International Classification of Diseases | 5 | 2021 | 934 | 0.410 |
Why?
|
| Antiretroviral Therapy, Highly Active | 7 | 2018 | 1899 | 0.400 |
Why?
|
| Reproducibility of Results | 36 | 2023 | 20135 | 0.400 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2018 | 3359 | 0.400 |
Why?
|
| Risk Factors | 76 | 2023 | 74838 | 0.400 |
Why?
|
| Graft Rejection | 4 | 2020 | 4504 | 0.400 |
Why?
|
| Carotid Arteries | 3 | 2014 | 932 | 0.390 |
Why?
|
| Ventricular Pressure | 7 | 2019 | 210 | 0.390 |
Why?
|
| HIV Seropositivity | 3 | 2013 | 961 | 0.380 |
Why?
|
| Marfan Syndrome | 4 | 2018 | 237 | 0.380 |
Why?
|
| Reference Values | 16 | 2023 | 4909 | 0.380 |
Why?
|
| Survivors | 9 | 2023 | 2375 | 0.380 |
Why?
|
| Biometry | 2 | 2013 | 571 | 0.370 |
Why?
|
| Societies, Medical | 11 | 2021 | 3955 | 0.360 |
Why?
|
| Cardiotoxins | 3 | 2017 | 35 | 0.360 |
Why?
|
| Aorta | 14 | 2018 | 2040 | 0.360 |
Why?
|
| Ventricular Function, Right | 6 | 2018 | 629 | 0.350 |
Why?
|
| Time Factors | 60 | 2019 | 40100 | 0.350 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 7 | 2011 | 1511 | 0.340 |
Why?
|
| Adult | 121 | 2024 | 223106 | 0.330 |
Why?
|
| Cardiotonic Agents | 6 | 2016 | 540 | 0.330 |
Why?
|
| Zidovudine | 3 | 2012 | 626 | 0.330 |
Why?
|
| Heart Septum | 9 | 2020 | 303 | 0.330 |
Why?
|
| Heart Septal Defects | 5 | 2017 | 191 | 0.320 |
Why?
|
| Amlodipine | 3 | 2023 | 84 | 0.320 |
Why?
|
| Coronary Vessel Anomalies | 9 | 1999 | 308 | 0.320 |
Why?
|
| Hypertrophy, Right Ventricular | 3 | 2000 | 109 | 0.320 |
Why?
|
| Risk Assessment | 34 | 2023 | 24272 | 0.310 |
Why?
|
| beta-Thalassemia | 2 | 2023 | 233 | 0.310 |
Why?
|
| Immunoglobulins, Intravenous | 5 | 2010 | 667 | 0.310 |
Why?
|
| Noonan Syndrome | 3 | 2023 | 122 | 0.310 |
Why?
|
| Death, Sudden | 1 | 2010 | 301 | 0.310 |
Why?
|
| Cardiovascular System | 3 | 2004 | 838 | 0.310 |
Why?
|
| Cardiovascular Agents | 3 | 2010 | 847 | 0.300 |
Why?
|
| Ultrasonography | 21 | 2013 | 5988 | 0.300 |
Why?
|
| Age Factors | 33 | 2020 | 18382 | 0.300 |
Why?
|
| Canada | 10 | 2019 | 2120 | 0.290 |
Why?
|
| Tetralogy of Fallot | 4 | 2023 | 629 | 0.290 |
Why?
|
| Genetic Testing | 5 | 2022 | 3592 | 0.290 |
Why?
|
| Natriuretic Peptide, Brain | 9 | 2018 | 1734 | 0.280 |
Why?
|
| Incidence | 33 | 2022 | 21509 | 0.280 |
Why?
|
| Organ Size | 9 | 2022 | 2260 | 0.280 |
Why?
|
| Survival Rate | 26 | 2021 | 12821 | 0.280 |
Why?
|
| Predictive Value of Tests | 28 | 2023 | 15401 | 0.280 |
Why?
|
| Echocardiography, Stress | 3 | 2020 | 137 | 0.270 |
Why?
|
| Health Status | 11 | 2018 | 4083 | 0.270 |
Why?
|
| Infectious Disease Transmission, Vertical | 11 | 2015 | 1354 | 0.270 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2008 | 271 | 0.260 |
Why?
|
| Propanolamines | 3 | 2016 | 163 | 0.260 |
Why?
|
| Boston | 17 | 2023 | 9336 | 0.260 |
Why?
|
| Practice Guidelines as Topic | 8 | 2022 | 7423 | 0.260 |
Why?
|
| Calcium Channel Blockers | 5 | 2023 | 686 | 0.260 |
Why?
|
| Blood Pressure | 19 | 2019 | 8529 | 0.260 |
Why?
|
| Lung Transplantation | 1 | 2015 | 1310 | 0.250 |
Why?
|
| Electrocardiography | 28 | 2018 | 6408 | 0.250 |
Why?
|
| Waiting Lists | 2 | 2012 | 779 | 0.250 |
Why?
|
| Fetal Heart | 6 | 2006 | 281 | 0.250 |
Why?
|
| Aortic Aneurysm | 3 | 2015 | 649 | 0.250 |
Why?
|
| Troponin T | 6 | 2018 | 785 | 0.250 |
Why?
|
| Exercise Test | 15 | 2022 | 2185 | 0.240 |
Why?
|
| Ventricular Dysfunction | 4 | 2016 | 143 | 0.240 |
Why?
|
| Algorithms | 7 | 2020 | 14065 | 0.240 |
Why?
|
| Genotype | 13 | 2022 | 13029 | 0.240 |
Why?
|
| Carbazoles | 3 | 2016 | 229 | 0.240 |
Why?
|
| Prognosis | 37 | 2023 | 29904 | 0.240 |
Why?
|
| United States | 44 | 2024 | 72916 | 0.240 |
Why?
|
| Vascular Surgical Procedures | 4 | 2012 | 1506 | 0.240 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2002 | 1097 | 0.240 |
Why?
|
| Disease Progression | 25 | 2022 | 13613 | 0.230 |
Why?
|
| Phenotype | 20 | 2023 | 16712 | 0.230 |
Why?
|
| Severity of Illness Index | 19 | 2020 | 15882 | 0.230 |
Why?
|
| Pulmonary Valve | 11 | 2016 | 413 | 0.230 |
Why?
|
| Reoperation | 15 | 2023 | 4308 | 0.230 |
Why?
|
| Tachycardia, Supraventricular | 6 | 2007 | 272 | 0.230 |
Why?
|
| Multivariate Analysis | 22 | 2017 | 12061 | 0.230 |
Why?
|
| Mutation | 15 | 2021 | 30208 | 0.230 |
Why?
|
| Kaplan-Meier Estimate | 13 | 2018 | 6506 | 0.230 |
Why?
|
| Aftercare | 4 | 2022 | 915 | 0.230 |
Why?
|
| Sensitivity and Specificity | 22 | 2016 | 14644 | 0.220 |
Why?
|
| HIV | 2 | 2011 | 1587 | 0.220 |
Why?
|
| Databases, Factual | 10 | 2021 | 8062 | 0.220 |
Why?
|
| Blood Flow Velocity | 9 | 2016 | 1378 | 0.220 |
Why?
|
| Survival Analysis | 15 | 2015 | 10089 | 0.220 |
Why?
|
| Maternal Exposure | 2 | 2011 | 1097 | 0.220 |
Why?
|
| Mutation, Missense | 4 | 2021 | 2590 | 0.220 |
Why?
|
| ROC Curve | 10 | 2020 | 3614 | 0.220 |
Why?
|
| LEOPARD Syndrome | 1 | 2023 | 12 | 0.220 |
Why?
|
| Triiodothyronine | 4 | 2016 | 493 | 0.220 |
Why?
|
| Heart Valves | 3 | 2020 | 284 | 0.220 |
Why?
|
| Vena Cava, Superior | 2 | 2006 | 197 | 0.220 |
Why?
|
| Human Growth Hormone | 2 | 2005 | 639 | 0.210 |
Why?
|
| Patient Care Management | 3 | 2011 | 301 | 0.210 |
Why?
|
| Cardiography, Impedance | 1 | 2003 | 40 | 0.210 |
Why?
|
| Proportional Hazards Models | 17 | 2020 | 12530 | 0.210 |
Why?
|
| Foramen Ovale | 1 | 2022 | 17 | 0.210 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2015 | 2535 | 0.210 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 2 | 2020 | 30 | 0.210 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2023 | 63 | 0.200 |
Why?
|
| Cohort Studies | 34 | 2022 | 41675 | 0.200 |
Why?
|
| Endocardium | 3 | 2000 | 249 | 0.200 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2003 | 101 | 0.200 |
Why?
|
| Single-Blind Method | 4 | 2017 | 1588 | 0.200 |
Why?
|
| Atrial Septum | 1 | 2022 | 61 | 0.200 |
Why?
|
| Anthropometry | 3 | 2004 | 1336 | 0.200 |
Why?
|
| Thalassemia | 3 | 2014 | 267 | 0.200 |
Why?
|
| Mortality | 3 | 2020 | 2908 | 0.200 |
Why?
|
| Image Enhancement | 4 | 2016 | 2857 | 0.200 |
Why?
|
| Progeria | 1 | 2024 | 182 | 0.190 |
Why?
|
| Cross-Sectional Studies | 28 | 2018 | 26280 | 0.190 |
Why?
|
| Ultrasonography, Prenatal | 9 | 2013 | 1772 | 0.190 |
Why?
|
| Consensus | 3 | 2018 | 3200 | 0.190 |
Why?
|
| Observer Variation | 6 | 2017 | 2611 | 0.190 |
Why?
|
| Atrial Fibrillation | 6 | 2021 | 5182 | 0.190 |
Why?
|
| Myocytes, Cardiac | 3 | 2020 | 1674 | 0.190 |
Why?
|
| Double Outlet Right Ventricle | 4 | 2010 | 60 | 0.190 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2021 | 43 | 0.190 |
Why?
|
| Heart Function Tests | 4 | 2012 | 316 | 0.190 |
Why?
|
| Length of Stay | 14 | 2019 | 6489 | 0.190 |
Why?
|
| Morbidity | 7 | 2021 | 1753 | 0.180 |
Why?
|
| Quality Improvement | 7 | 2018 | 3849 | 0.180 |
Why?
|
| Aortic Aneurysm, Thoracic | 3 | 2012 | 708 | 0.180 |
Why?
|
| Tricuspid Valve | 10 | 2018 | 420 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 14 | 2023 | 18076 | 0.180 |
Why?
|
| Cardiovascular Diseases | 8 | 2021 | 15639 | 0.180 |
Why?
|
| Cardiology Service, Hospital | 3 | 2011 | 242 | 0.180 |
Why?
|
| Pregnancy | 24 | 2020 | 30227 | 0.180 |
Why?
|
| Quality Indicators, Health Care | 4 | 2015 | 1804 | 0.180 |
Why?
|
| Defibrillators, Implantable | 5 | 2020 | 1496 | 0.170 |
Why?
|
| Fibrosis | 9 | 2023 | 2073 | 0.170 |
Why?
|
| Clinical Competence | 6 | 2016 | 4859 | 0.170 |
Why?
|
| Exercise | 7 | 2012 | 5939 | 0.170 |
Why?
|
| Inheritance Patterns | 1 | 2022 | 345 | 0.160 |
Why?
|
| Myocarditis | 7 | 2012 | 802 | 0.160 |
Why?
|
| Preoperative Care | 7 | 2003 | 2249 | 0.160 |
Why?
|
| Longitudinal Studies | 17 | 2018 | 14747 | 0.160 |
Why?
|
| Coronary Circulation | 6 | 2016 | 1601 | 0.160 |
Why?
|
| Pulmonary Veins | 4 | 2011 | 759 | 0.160 |
Why?
|
| Iron | 4 | 2023 | 1810 | 0.160 |
Why?
|
| Osteosarcoma | 2 | 2023 | 908 | 0.160 |
Why?
|
| Pulse | 4 | 2009 | 217 | 0.160 |
Why?
|
| Patient Discharge | 5 | 2022 | 3464 | 0.150 |
Why?
|
| Linear Models | 12 | 2018 | 5872 | 0.150 |
Why?
|
| Aging | 7 | 2024 | 8722 | 0.150 |
Why?
|
| Scoliosis | 3 | 2003 | 793 | 0.150 |
Why?
|
| Life Tables | 5 | 2006 | 366 | 0.150 |
Why?
|
| Dobutamine | 4 | 1992 | 114 | 0.150 |
Why?
|
| Mitral Valve Stenosis | 4 | 2023 | 342 | 0.150 |
Why?
|
| Hospitals, Pediatric | 6 | 2016 | 1850 | 0.150 |
Why?
|
| Oxygen Consumption | 3 | 2016 | 1870 | 0.150 |
Why?
|
| Electric Countershock | 2 | 2020 | 534 | 0.150 |
Why?
|
| Postoperative Period | 10 | 2018 | 1820 | 0.150 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2004 | 643 | 0.150 |
Why?
|
| Atrial Function | 1 | 2018 | 98 | 0.150 |
Why?
|
| Genetic Variation | 4 | 2022 | 6611 | 0.150 |
Why?
|
| Chelation Therapy | 1 | 2018 | 76 | 0.150 |
Why?
|
| Echocardiography, Doppler, Color | 7 | 2016 | 353 | 0.150 |
Why?
|
| Forms and Records Control | 2 | 2017 | 158 | 0.150 |
Why?
|
| Disease-Free Survival | 8 | 2017 | 6840 | 0.150 |
Why?
|
| Vasodilator Agents | 2 | 1998 | 988 | 0.150 |
Why?
|
| Fetal Diseases | 5 | 2010 | 915 | 0.150 |
Why?
|
| Verapamil | 1 | 1998 | 242 | 0.150 |
Why?
|
| Contrast Media | 2 | 2023 | 5329 | 0.150 |
Why?
|
| Cardiovascular Abnormalities | 3 | 2011 | 148 | 0.140 |
Why?
|
| Echocardiography, Doppler, Pulsed | 3 | 2014 | 68 | 0.140 |
Why?
|
| Sheep | 11 | 2000 | 1445 | 0.140 |
Why?
|
| Double-Blind Method | 11 | 2024 | 12426 | 0.140 |
Why?
|
| Methoxamine | 4 | 1985 | 45 | 0.140 |
Why?
|
| Catecholamines | 3 | 2016 | 388 | 0.140 |
Why?
|
| Heart-Assist Devices | 4 | 2021 | 1283 | 0.130 |
Why?
|
| Critical Pathways | 2 | 2010 | 475 | 0.130 |
Why?
|
| Recovery of Function | 4 | 2019 | 2971 | 0.130 |
Why?
|
| Sports | 2 | 1997 | 699 | 0.130 |
Why?
|
| Child Nutrition Disorders | 1 | 2018 | 139 | 0.130 |
Why?
|
| Analysis of Variance | 10 | 2018 | 6208 | 0.130 |
Why?
|
| Drug Administration Schedule | 7 | 2018 | 4853 | 0.130 |
Why?
|
| North America | 6 | 2017 | 1287 | 0.130 |
Why?
|
| Electrocardiography, Ambulatory | 10 | 2007 | 582 | 0.130 |
Why?
|
| Pacemaker, Artificial | 3 | 2012 | 828 | 0.130 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2012 | 1737 | 0.130 |
Why?
|
| Adaptation, Physiological | 5 | 2015 | 1310 | 0.130 |
Why?
|
| Blood Transfusion | 2 | 2018 | 1307 | 0.130 |
Why?
|
| Employee Performance Appraisal | 1 | 2016 | 86 | 0.130 |
Why?
|
| Carrier Proteins | 5 | 2021 | 4910 | 0.130 |
Why?
|
| Cardiac Output | 6 | 2016 | 838 | 0.130 |
Why?
|
| Antihypertensive Agents | 2 | 2019 | 2028 | 0.130 |
Why?
|
| Peptide Fragments | 4 | 2013 | 5125 | 0.120 |
Why?
|
| Iron Chelating Agents | 2 | 2023 | 141 | 0.120 |
Why?
|
| Perinatal Care | 1 | 2017 | 244 | 0.120 |
Why?
|
| Catheter Ablation | 8 | 2007 | 2787 | 0.120 |
Why?
|
| Heart Rate | 11 | 2021 | 4203 | 0.120 |
Why?
|
| Receptors, Adrenergic | 1 | 2014 | 155 | 0.120 |
Why?
|
| Infusions, Intravenous | 7 | 2012 | 2227 | 0.120 |
Why?
|
| Pulmonary Circulation | 2 | 2015 | 744 | 0.120 |
Why?
|
| Diltiazem | 1 | 2014 | 132 | 0.110 |
Why?
|
| Time | 1 | 2016 | 549 | 0.110 |
Why?
|
| Neoplasms | 8 | 2024 | 22336 | 0.110 |
Why?
|
| Fetal Therapies | 2 | 2006 | 101 | 0.110 |
Why?
|
| Hypertension | 7 | 2002 | 8609 | 0.110 |
Why?
|
| Odds Ratio | 9 | 2015 | 9655 | 0.110 |
Why?
|
| Swimming | 3 | 1991 | 212 | 0.110 |
Why?
|
| Quality of Life | 6 | 2017 | 13463 | 0.110 |
Why?
|
| Case-Control Studies | 11 | 2022 | 22231 | 0.110 |
Why?
|
| Chi-Square Distribution | 7 | 2014 | 3431 | 0.110 |
Why?
|
| Stress, Mechanical | 7 | 2009 | 1670 | 0.110 |
Why?
|
| Creatine Kinase | 5 | 2006 | 682 | 0.110 |
Why?
|
| Anti-HIV Agents | 3 | 2012 | 4561 | 0.110 |
Why?
|
| Tricuspid Atresia | 1 | 2013 | 37 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2005 | 11858 | 0.110 |
Why?
|
| Cause of Death | 6 | 2018 | 3712 | 0.110 |
Why?
|
| Tissue and Organ Procurement | 1 | 2022 | 988 | 0.110 |
Why?
|
| Prevalence | 13 | 2018 | 15820 | 0.110 |
Why?
|
| Calcium Channels, L-Type | 1 | 2014 | 243 | 0.110 |
Why?
|
| Zalcitabine | 1 | 2012 | 43 | 0.100 |
Why?
|
| Dilatation | 3 | 2023 | 311 | 0.100 |
Why?
|
| Heterozygote | 3 | 2014 | 2796 | 0.100 |
Why?
|
| Logistic Models | 14 | 2015 | 13272 | 0.100 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2011 | 949 | 0.100 |
Why?
|
| Coronary Aneurysm | 1 | 2015 | 234 | 0.100 |
Why?
|
| Age of Onset | 4 | 2022 | 3342 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 3 | 2015 | 2504 | 0.100 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2014 | 193 | 0.100 |
Why?
|
| Dideoxynucleosides | 1 | 2013 | 135 | 0.100 |
Why?
|
| Australia | 4 | 2018 | 1260 | 0.100 |
Why?
|
| Middle Aged | 41 | 2021 | 223025 | 0.100 |
Why?
|
| Patient Selection | 6 | 2012 | 4249 | 0.100 |
Why?
|
| Immunoglobulins | 1 | 1995 | 853 | 0.100 |
Why?
|
| Models, Statistical | 3 | 2020 | 5088 | 0.100 |
Why?
|
| Decision Support Techniques | 3 | 2023 | 2005 | 0.100 |
Why?
|
| Exercise Tolerance | 3 | 2015 | 841 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 15 | 2018 | 36545 | 0.100 |
Why?
|
| History, 21st Century | 3 | 2017 | 1574 | 0.100 |
Why?
|
| Hemochromatosis | 1 | 2013 | 175 | 0.100 |
Why?
|
| Immunization, Passive | 3 | 1994 | 616 | 0.100 |
Why?
|
| Palliative Care | 9 | 2013 | 3639 | 0.100 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2012 | 139 | 0.100 |
Why?
|
| Subclavian Artery | 1 | 1992 | 138 | 0.100 |
Why?
|
| Biopsy | 3 | 2020 | 6768 | 0.090 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2011 | 64 | 0.090 |
Why?
|
| Ventricular Fibrillation | 2 | 2012 | 538 | 0.090 |
Why?
|
| Costello Syndrome | 1 | 2011 | 19 | 0.090 |
Why?
|
| Hospital Costs | 3 | 2014 | 955 | 0.090 |
Why?
|
| Connecticut | 1 | 2011 | 365 | 0.090 |
Why?
|
| Myocardial Bridging | 1 | 2010 | 10 | 0.090 |
Why?
|
| Forecasting | 3 | 2017 | 2935 | 0.090 |
Why?
|
| Antineoplastic Agents | 4 | 2015 | 13634 | 0.090 |
Why?
|
| Early Termination of Clinical Trials | 1 | 2011 | 70 | 0.090 |
Why?
|
| Databases as Topic | 2 | 2012 | 472 | 0.090 |
Why?
|
| Comorbidity | 5 | 2012 | 10577 | 0.090 |
Why?
|
| Postoperative Care | 2 | 2016 | 1475 | 0.090 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 2 | 2001 | 15 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2015 | 8925 | 0.090 |
Why?
|
| Troponin | 3 | 2010 | 532 | 0.090 |
Why?
|
| Corrosion Casting | 2 | 2000 | 15 | 0.090 |
Why?
|
| Ontario | 3 | 2017 | 403 | 0.090 |
Why?
|
| Hospital Mortality | 8 | 2013 | 5339 | 0.090 |
Why?
|
| Coronary Artery Disease | 4 | 2012 | 6540 | 0.090 |
Why?
|
| Heart Arrest | 2 | 2020 | 1516 | 0.090 |
Why?
|
| Bone Neoplasms | 1 | 2023 | 2559 | 0.090 |
Why?
|
| Silicone Elastomers | 2 | 2000 | 78 | 0.090 |
Why?
|
| Dextrocardia | 1 | 2010 | 37 | 0.090 |
Why?
|
| Vinblastine | 1 | 2011 | 482 | 0.090 |
Why?
|
| Transplantation | 1 | 2012 | 222 | 0.090 |
Why?
|
| History, 20th Century | 3 | 2017 | 2762 | 0.090 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2011 | 168 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5752 | 0.090 |
Why?
|
| Procollagen | 1 | 2010 | 189 | 0.080 |
Why?
|
| Wounds and Injuries | 2 | 2012 | 2513 | 0.080 |
Why?
|
| Electronic Health Records | 2 | 2017 | 4863 | 0.080 |
Why?
|
| Radiography | 7 | 2013 | 6943 | 0.080 |
Why?
|
| Child of Impaired Parents | 1 | 2013 | 462 | 0.080 |
Why?
|
| Anastomosis, Surgical | 5 | 2012 | 992 | 0.080 |
Why?
|
| Muscular Dystrophies | 2 | 2007 | 392 | 0.080 |
Why?
|
| Puerto Rico | 1 | 2010 | 380 | 0.080 |
Why?
|
| Postpartum Period | 1 | 1996 | 1195 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1512 | 0.080 |
Why?
|
| Regional Blood Flow | 2 | 2010 | 1479 | 0.080 |
Why?
|
| Databases, Genetic | 1 | 2016 | 1755 | 0.080 |
Why?
|
| Ferritins | 3 | 2023 | 600 | 0.080 |
Why?
|
| Pilot Projects | 8 | 2020 | 8722 | 0.080 |
Why?
|
| Cost of Illness | 1 | 2018 | 1949 | 0.080 |
Why?
|
| Models, Biological | 1 | 2004 | 9446 | 0.080 |
Why?
|
| Intubation, Intratracheal | 1 | 2016 | 1359 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2016 | 1563 | 0.080 |
Why?
|
| Tachycardia, Ventricular | 3 | 2012 | 1313 | 0.070 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2010 | 772 | 0.070 |
Why?
|
| Fever | 3 | 2013 | 1607 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2000 | 3560 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2018 | 2046 | 0.070 |
Why?
|
| Tachycardia | 4 | 2004 | 598 | 0.070 |
Why?
|
| Friedreich Ataxia | 1 | 2008 | 82 | 0.070 |
Why?
|
| Ablation Techniques | 1 | 2010 | 254 | 0.070 |
Why?
|
| Syncope | 1 | 2010 | 431 | 0.070 |
Why?
|
| Aorta, Abdominal | 1 | 2010 | 626 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 2003 | 2677 | 0.070 |
Why?
|
| Abnormalities, Multiple | 4 | 2004 | 1424 | 0.070 |
Why?
|
| Standard of Care | 1 | 2011 | 568 | 0.070 |
Why?
|
| Diagnosis, Differential | 8 | 2007 | 12975 | 0.070 |
Why?
|
| Turner Syndrome | 1 | 2008 | 129 | 0.070 |
Why?
|
| Learning | 1 | 2016 | 1754 | 0.070 |
Why?
|
| Sex Factors | 7 | 2017 | 10611 | 0.070 |
Why?
|
| Renin-Angiotensin System | 1 | 2011 | 736 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2016 | 5383 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 1241 | 0.060 |
Why?
|
| American Hospital Association | 1 | 2005 | 26 | 0.060 |
Why?
|
| Aged | 23 | 2023 | 171161 | 0.060 |
Why?
|
| Discriminant Analysis | 1 | 2006 | 222 | 0.060 |
Why?
|
| Age Distribution | 3 | 2014 | 2865 | 0.060 |
Why?
|
| Child Development | 2 | 2014 | 2327 | 0.060 |
Why?
|
| World Health Organization | 3 | 2021 | 1326 | 0.060 |
Why?
|
| ras Proteins | 1 | 2011 | 1054 | 0.060 |
Why?
|
| Consanguinity | 2 | 2006 | 460 | 0.060 |
Why?
|
| Methylprednisolone | 1 | 2007 | 386 | 0.060 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2018 | 280 | 0.060 |
Why?
|
| Data Collection | 3 | 2023 | 3318 | 0.060 |
Why?
|
| Gestational Age | 8 | 2010 | 3616 | 0.060 |
Why?
|
| Advisory Committees | 3 | 2017 | 796 | 0.060 |
Why?
|
| Methotrexate | 1 | 2011 | 1719 | 0.060 |
Why?
|
| Renal Dialysis | 3 | 2015 | 1791 | 0.060 |
Why?
|
| Body Surface Potential Mapping | 2 | 1997 | 228 | 0.060 |
Why?
|
| Daunorubicin | 1 | 1985 | 157 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2010 | 1592 | 0.060 |
Why?
|
| Isoenzymes | 3 | 2003 | 1688 | 0.060 |
Why?
|
| Disease Management | 1 | 2015 | 2530 | 0.060 |
Why?
|
| Reference Standards | 1 | 2008 | 1011 | 0.060 |
Why?
|
| Ebstein Anomaly | 1 | 2005 | 106 | 0.060 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2005 | 66 | 0.060 |
Why?
|
| Career Choice | 1 | 2011 | 768 | 0.060 |
Why?
|
| Sports Medicine | 1 | 1987 | 239 | 0.060 |
Why?
|
| Axillary Artery | 1 | 1984 | 48 | 0.060 |
Why?
|
| Heart Block | 3 | 2004 | 391 | 0.060 |
Why?
|
| Ethanol | 1 | 2010 | 1326 | 0.060 |
Why?
|
| Coronary Disease | 4 | 2007 | 5914 | 0.060 |
Why?
|
| Sex Distribution | 2 | 2014 | 2269 | 0.060 |
Why?
|
| Pregnancy Trimester, Second | 3 | 1996 | 737 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3405 | 0.060 |
Why?
|
| Immunologic Factors | 2 | 2010 | 1592 | 0.060 |
Why?
|
| Myopathy, Central Core | 1 | 2003 | 4 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 1490 | 0.060 |
Why?
|
| Health Resources | 1 | 2010 | 951 | 0.060 |
Why?
|
| United Arab Emirates | 1 | 2003 | 42 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 11906 | 0.060 |
Why?
|
| Weight Lifting | 3 | 1992 | 130 | 0.060 |
Why?
|
| Oklahoma | 1 | 2003 | 36 | 0.050 |
Why?
|
| Vascular Resistance | 3 | 2016 | 939 | 0.050 |
Why?
|
| Southwestern United States | 1 | 2003 | 39 | 0.050 |
Why?
|
| Myosins | 2 | 2010 | 407 | 0.050 |
Why?
|
| Polymorphism, Genetic | 3 | 2020 | 4249 | 0.050 |
Why?
|
| Truncus Arteriosus | 1 | 2023 | 22 | 0.050 |
Why?
|
| Troponin I | 2 | 2014 | 656 | 0.050 |
Why?
|
| Intensive Care Units | 4 | 2013 | 3798 | 0.050 |
Why?
|
| Drug Therapy, Combination | 4 | 2018 | 6307 | 0.050 |
Why?
|
| Infant Welfare | 1 | 2003 | 78 | 0.050 |
Why?
|
| Rabbits | 3 | 2009 | 4730 | 0.050 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2016 | 1021 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2018 | 4545 | 0.050 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 831 | 0.050 |
Why?
|
| Torticollis | 1 | 2003 | 69 | 0.050 |
Why?
|
| Hypopituitarism | 1 | 2005 | 253 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 1994 | 2205 | 0.050 |
Why?
|
| Endocarditis, Bacterial | 1 | 2007 | 434 | 0.050 |
Why?
|
| Mediastinum | 1 | 2004 | 272 | 0.050 |
Why?
|
| Mathematical Computing | 1 | 2003 | 142 | 0.050 |
Why?
|
| Anemia, Sickle Cell | 1 | 2011 | 1063 | 0.050 |
Why?
|
| Physical Exertion | 1 | 1985 | 666 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2017 | 325 | 0.050 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2006 | 386 | 0.050 |
Why?
|
| Animals | 22 | 2020 | 168775 | 0.050 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2013 | 60 | 0.050 |
Why?
|
| Down Syndrome | 1 | 2010 | 915 | 0.050 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 2001 | 202 | 0.050 |
Why?
|
| Uremia | 1 | 2003 | 202 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2012 | 2171 | 0.050 |
Why?
|
| Regression Analysis | 4 | 2007 | 6324 | 0.050 |
Why?
|
| Fourier Analysis | 1 | 2003 | 434 | 0.050 |
Why?
|
| Research Design | 5 | 2016 | 6205 | 0.050 |
Why?
|
| Captopril | 1 | 1982 | 261 | 0.050 |
Why?
|
| Phonocardiography | 3 | 1987 | 30 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5695 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2018 | 10736 | 0.050 |
Why?
|
| Glucocorticoids | 2 | 2011 | 2156 | 0.050 |
Why?
|
| History, 19th Century | 2 | 2017 | 711 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2006 | 1331 | 0.050 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2021 | 80 | 0.050 |
Why?
|
| Kidney Function Tests | 2 | 2015 | 684 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2008 | 2844 | 0.050 |
Why?
|
| Feasibility Studies | 5 | 2012 | 5301 | 0.050 |
Why?
|
| Williams Syndrome | 1 | 2003 | 195 | 0.050 |
Why?
|
| Sudden Infant Death | 1 | 1984 | 293 | 0.050 |
Why?
|
| Safety | 1 | 2005 | 1157 | 0.050 |
Why?
|
| Quality of Health Care | 2 | 2020 | 4306 | 0.040 |
Why?
|
| Kyphosis | 1 | 2003 | 252 | 0.040 |
Why?
|
| Tachycardia, Paroxysmal | 2 | 1996 | 30 | 0.040 |
Why?
|
| Protein Precursors | 2 | 2018 | 1133 | 0.040 |
Why?
|
| Proline | 1 | 1982 | 453 | 0.040 |
Why?
|
| Pedigree | 3 | 2003 | 4535 | 0.040 |
Why?
|
| Constriction, Pathologic | 2 | 2022 | 1102 | 0.040 |
Why?
|
| Inflammation | 2 | 2018 | 10857 | 0.040 |
Why?
|
| Program Development | 3 | 2011 | 1297 | 0.040 |
Why?
|
| Aspirin | 2 | 2007 | 3135 | 0.040 |
Why?
|
| Pregnancy Outcome | 3 | 2007 | 2969 | 0.040 |
Why?
|
| New England | 1 | 2003 | 1059 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2005 | 870 | 0.040 |
Why?
|
| Myofibrils | 1 | 2020 | 143 | 0.040 |
Why?
|
| Muscle Relaxation | 1 | 2020 | 138 | 0.040 |
Why?
|
| Electrodes | 3 | 1997 | 610 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 1983 | 646 | 0.040 |
Why?
|
| Edema | 1 | 2023 | 763 | 0.040 |
Why?
|
| Wisconsin | 1 | 2019 | 122 | 0.040 |
Why?
|
| Rheumatic Heart Disease | 1 | 2001 | 163 | 0.040 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2012 | 2586 | 0.040 |
Why?
|
| Clinical Coding | 2 | 2011 | 187 | 0.040 |
Why?
|
| Mitochondria, Heart | 1 | 2000 | 228 | 0.040 |
Why?
|
| Child Welfare | 1 | 2003 | 521 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2003 | 945 | 0.040 |
Why?
|
| Hypotension | 1 | 1985 | 885 | 0.040 |
Why?
|
| Chelating Agents | 2 | 2014 | 380 | 0.040 |
Why?
|
| Vascular Fistula | 1 | 1999 | 50 | 0.040 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2005 | 1195 | 0.040 |
Why?
|
| Lung | 2 | 2015 | 10060 | 0.040 |
Why?
|
| C-Reactive Protein | 3 | 2018 | 3853 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2002 | 553 | 0.040 |
Why?
|
| Mothers | 2 | 2023 | 2206 | 0.040 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2019 | 277 | 0.040 |
Why?
|
| Transplantation, Homologous | 3 | 2012 | 4860 | 0.040 |
Why?
|
| Acute Disease | 5 | 2011 | 7237 | 0.040 |
Why?
|
| Ventricular Septum | 1 | 2018 | 76 | 0.040 |
Why?
|
| Gadolinium | 1 | 2023 | 966 | 0.040 |
Why?
|
| Aortic Arch Syndromes | 1 | 1998 | 19 | 0.040 |
Why?
|
| Congresses as Topic | 2 | 2015 | 811 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2003 | 18314 | 0.040 |
Why?
|
| Virus Diseases | 2 | 1994 | 720 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1999 | 437 | 0.040 |
Why?
|
| DiGeorge Syndrome | 1 | 1999 | 187 | 0.040 |
Why?
|
| Health Personnel | 1 | 2011 | 3382 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 1985 | 1187 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2011 | 3928 | 0.040 |
Why?
|
| Kidney Transplantation | 2 | 2015 | 4277 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 1276 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 13082 | 0.040 |
Why?
|
| Denmark | 1 | 2019 | 774 | 0.040 |
Why?
|
| Physical Examination | 1 | 2003 | 1263 | 0.040 |
Why?
|
| AIDS Dementia Complex | 1 | 1998 | 154 | 0.030 |
Why?
|
| Cost Savings | 2 | 2014 | 901 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2009 | 2520 | 0.030 |
Why?
|
| HIV-1 | 3 | 2002 | 6948 | 0.030 |
Why?
|
| Digoxin | 2 | 2012 | 246 | 0.030 |
Why?
|
| Serum | 1 | 2018 | 205 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2023 | 1707 | 0.030 |
Why?
|
| Artifacts | 1 | 2005 | 1896 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2020 | 422 | 0.030 |
Why?
|
| Ethers | 1 | 1996 | 72 | 0.030 |
Why?
|
| Missouri | 1 | 2016 | 112 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2011 | 4053 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4423 | 0.030 |
Why?
|
| Virulence | 1 | 2020 | 1290 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 2005 | 1134 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2018 | 10380 | 0.030 |
Why?
|
| Risk | 3 | 2002 | 9598 | 0.030 |
Why?
|
| Halothane | 1 | 1996 | 200 | 0.030 |
Why?
|
| Hodgkin Disease | 1 | 2004 | 1383 | 0.030 |
Why?
|
| Thyroid Hormones | 1 | 1999 | 408 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2020 | 1638 | 0.030 |
Why?
|
| Causality | 2 | 2016 | 1247 | 0.030 |
Why?
|
| Medicaid | 1 | 2009 | 2834 | 0.030 |
Why?
|
| Growth Disorders | 2 | 2011 | 633 | 0.030 |
Why?
|
| Milrinone | 1 | 2016 | 87 | 0.030 |
Why?
|
| Anesthesia, Inhalation | 1 | 1996 | 220 | 0.030 |
Why?
|
| Patient Admission | 1 | 2003 | 1364 | 0.030 |
Why?
|
| Nomograms | 1 | 2017 | 235 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2004 | 1263 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2020 | 839 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2018 | 565 | 0.030 |
Why?
|
| Clinical Trials as Topic | 3 | 2006 | 8037 | 0.030 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 1996 | 65 | 0.030 |
Why?
|
| Brazil | 1 | 2019 | 1248 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2004 | 1161 | 0.030 |
Why?
|
| Methyl Ethers | 1 | 1996 | 196 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2011 | 3458 | 0.030 |
Why?
|
| Heart Conduction System | 2 | 2004 | 1007 | 0.030 |
Why?
|
| Running | 2 | 1992 | 488 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2014 | 52 | 0.030 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2014 | 69 | 0.030 |
Why?
|
| Interprofessional Relations | 2 | 2011 | 998 | 0.030 |
Why?
|
| Massachusetts | 3 | 2012 | 8882 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 2 | 1998 | 1092 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 4112 | 0.030 |
Why?
|
| Ohio | 1 | 2015 | 320 | 0.030 |
Why?
|
| Sample Size | 1 | 2017 | 843 | 0.030 |
Why?
|
| Recurrence | 4 | 2016 | 8494 | 0.030 |
Why?
|
| Fetal Death | 2 | 2006 | 434 | 0.030 |
Why?
|
| Pulmonary Subvalvular Stenosis | 1 | 1993 | 7 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 1996 | 587 | 0.030 |
Why?
|
| Education, Medical | 1 | 2005 | 1744 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2014 | 216 | 0.030 |
Why?
|
| Ligation | 1 | 1994 | 446 | 0.030 |
Why?
|
| Elasticity | 1 | 2015 | 652 | 0.030 |
Why?
|
| Pulmonary Ventilation | 1 | 2015 | 375 | 0.030 |
Why?
|
| Decision Trees | 1 | 2015 | 508 | 0.030 |
Why?
|
| Heart Valve Prosthesis | 3 | 1997 | 1464 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2016 | 548 | 0.030 |
Why?
|
| Coronary Angiography | 4 | 2012 | 4496 | 0.030 |
Why?
|
| Prenatal Diagnosis | 3 | 1996 | 1271 | 0.030 |
Why?
|
| Cell Enlargement | 1 | 2013 | 58 | 0.030 |
Why?
|
| Apoptosis | 1 | 2009 | 9507 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2000 | 1158 | 0.030 |
Why?
|
| Dextrans | 2 | 1985 | 569 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 1995 | 463 | 0.030 |
Why?
|
| Respiration, Artificial | 3 | 2012 | 2727 | 0.030 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 1993 | 148 | 0.030 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 614 | 0.030 |
Why?
|
| Ploidies | 1 | 2013 | 287 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 2001 | 1322 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2012 | 97 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2005 | 4045 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 5528 | 0.020 |
Why?
|
| Status Asthmaticus | 1 | 1991 | 21 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2020 | 3947 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2022 | 2389 | 0.020 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2012 | 147 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 1996 | 917 | 0.020 |
Why?
|
| Cardiac Output, Low | 1 | 1992 | 192 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 1998 | 946 | 0.020 |
Why?
|
| gamma-Globulins | 1 | 1991 | 119 | 0.020 |
Why?
|
| Anesthetics, Inhalation | 1 | 1996 | 572 | 0.020 |
Why?
|
| Isoproterenol | 1 | 1991 | 398 | 0.020 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2016 | 606 | 0.020 |
Why?
|
| Stroke | 3 | 2020 | 9743 | 0.020 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2013 | 291 | 0.020 |
Why?
|
| Atrophy | 1 | 1996 | 1627 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2017 | 2603 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 8524 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2004 | 6254 | 0.020 |
Why?
|
| Graft Survival | 1 | 2022 | 3904 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2011 | 119 | 0.020 |
Why?
|
| Protamines | 1 | 1991 | 112 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 3051 | 0.020 |
Why?
|
| Motion | 1 | 1994 | 782 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2016 | 1437 | 0.020 |
Why?
|
| Angiotensins | 1 | 2011 | 139 | 0.020 |
Why?
|
| Texas | 1 | 2011 | 409 | 0.020 |
Why?
|
| Thyrotropin-Releasing Hormone | 2 | 2001 | 139 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 1997 | 1457 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2014 | 1494 | 0.020 |
Why?
|
| DNA Primers | 1 | 2014 | 2823 | 0.020 |
Why?
|
| Adenoma | 1 | 2001 | 2155 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1998 | 4016 | 0.020 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2004 | 511 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2020 | 2646 | 0.020 |
Why?
|
| Survival | 1 | 2010 | 160 | 0.020 |
Why?
|
| Lactates | 1 | 1991 | 398 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2012 | 462 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2015 | 1186 | 0.020 |
Why?
|
| Myofibroblasts | 1 | 2011 | 230 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2020 | 13042 | 0.020 |
Why?
|
| Random Allocation | 2 | 1996 | 2394 | 0.020 |
Why?
|
| Tropomyosin | 1 | 2010 | 103 | 0.020 |
Why?
|
| Cancer Care Facilities | 1 | 2012 | 427 | 0.020 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 5510 | 0.020 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2011 | 324 | 0.020 |
Why?
|
| Arterio-Arterial Fistula | 1 | 1989 | 20 | 0.020 |
Why?
|
| Genetic Counseling | 1 | 2013 | 634 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2010 | 418 | 0.020 |
Why?
|
| Portraits as Topic | 1 | 2008 | 33 | 0.020 |
Why?
|
| Nutritional Status | 1 | 1997 | 1620 | 0.020 |
Why?
|
| Viral Load | 2 | 2013 | 3386 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2020 | 18964 | 0.020 |
Why?
|
| Evidence-Based Medicine | 2 | 2011 | 3689 | 0.020 |
Why?
|
| Renin | 1 | 2011 | 647 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2012 | 636 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2020 | 2897 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2010 | 434 | 0.020 |
Why?
|
| Chronic Disease | 3 | 2012 | 9351 | 0.020 |
Why?
|
| Organizational Objectives | 1 | 2010 | 426 | 0.020 |
Why?
|
| Angiocardiography | 1 | 1988 | 149 | 0.020 |
Why?
|
| Prolactin | 2 | 2001 | 626 | 0.020 |
Why?
|
| Educational Status | 1 | 2015 | 2507 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 1884 | 0.020 |
Why?
|
| Methods | 1 | 1988 | 1061 | 0.020 |
Why?
|
| International Cooperation | 2 | 2005 | 1433 | 0.020 |
Why?
|
| Hyperemia | 1 | 2009 | 223 | 0.020 |
Why?
|
| Pressure | 3 | 1988 | 1171 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2014 | 3623 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1992 | 956 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2012 | 752 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2013 | 961 | 0.020 |
Why?
|
| Pulse Therapy, Drug | 1 | 2007 | 37 | 0.020 |
Why?
|
| England | 1 | 2008 | 533 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2015 | 996 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2011 | 1605 | 0.020 |
Why?
|
| Brachial Artery | 1 | 2009 | 373 | 0.020 |
Why?
|
| Income | 1 | 2015 | 1874 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2010 | 616 | 0.020 |
Why?
|
| Health Care Rationing | 1 | 2010 | 435 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 1991 | 703 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 731 | 0.020 |
Why?
|
| Thyrotropin | 2 | 2001 | 834 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2013 | 10431 | 0.020 |
Why?
|
| Myocardial Ischemia | 2 | 1994 | 2130 | 0.020 |
Why?
|
| Abortion, Therapeutic | 1 | 2006 | 35 | 0.020 |
Why?
|
| Adaptation, Biological | 1 | 1987 | 147 | 0.020 |
Why?
|
| Aldosterone | 1 | 2011 | 881 | 0.020 |
Why?
|
| Atrial Appendage | 1 | 2010 | 284 | 0.020 |
Why?
|
| Office Visits | 1 | 2010 | 594 | 0.020 |
Why?
|
| Liver | 2 | 2018 | 7558 | 0.020 |
Why?
|
| Comprehension | 1 | 2011 | 636 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 1885 | 0.020 |
Why?
|
| Fingers | 1 | 2009 | 509 | 0.020 |
Why?
|
| Leukopenia | 1 | 2006 | 213 | 0.020 |
Why?
|
| Medical Records | 2 | 2002 | 1408 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2022 | 9524 | 0.020 |
Why?
|
| Lactic Acid | 1 | 1991 | 1137 | 0.020 |
Why?
|
| Twins, Conjoined | 1 | 1985 | 41 | 0.020 |
Why?
|
| Dwarfism | 1 | 2006 | 137 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 3 | 1993 | 1607 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 8105 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3801 | 0.010 |
Why?
|
| Cell Count | 1 | 2009 | 1825 | 0.010 |
Why?
|
| Deferoxamine | 1 | 1985 | 154 | 0.010 |
Why?
|
| Body Weight | 2 | 2010 | 4626 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2013 | 2921 | 0.010 |
Why?
|
| Acyltransferases | 1 | 2006 | 305 | 0.010 |
Why?
|
| Monitoring, Physiologic | 3 | 1989 | 1794 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 59493 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 2008 | 771 | 0.010 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2010 | 669 | 0.010 |
Why?
|
| Cardiac Complexes, Premature | 1 | 1984 | 63 | 0.010 |
Why?
|
| Prealbumin | 1 | 2006 | 261 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2011 | 1491 | 0.010 |
Why?
|
| Weight Gain | 1 | 2014 | 2356 | 0.010 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 1480 | 0.010 |
Why?
|
| Regeneration | 1 | 2013 | 1516 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2010 | 1319 | 0.010 |
Why?
|
| Base Sequence | 1 | 2014 | 12405 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4779 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2009 | 2915 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2006 | 633 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 2003 | 189 | 0.010 |
Why?
|
| Hand Strength | 1 | 2006 | 464 | 0.010 |
Why?
|
| Muscle Weakness | 1 | 2006 | 412 | 0.010 |
Why?
|
| Cytokines | 1 | 2018 | 7425 | 0.010 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2006 | 291 | 0.010 |
Why?
|
| Probability | 1 | 2008 | 2475 | 0.010 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 1984 | 117 | 0.010 |
Why?
|
| Syndrome | 2 | 2006 | 3270 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1765 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 2004 | 209 | 0.010 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2003 | 202 | 0.010 |
Why?
|
| Health Services Research | 1 | 2010 | 1811 | 0.010 |
Why?
|
| Medical History Taking | 1 | 2006 | 779 | 0.010 |
Why?
|
| Fibrinolytic Agents | 1 | 2012 | 2077 | 0.010 |
Why?
|
| Growth | 1 | 2004 | 365 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2004 | 416 | 0.010 |
Why?
|
| Education, Medical, Continuing | 1 | 2008 | 829 | 0.010 |
Why?
|
| Spinal Fusion | 1 | 1992 | 1307 | 0.010 |
Why?
|
| Digitoxin | 1 | 1982 | 19 | 0.010 |
Why?
|
| Peritoneal Dialysis | 1 | 2003 | 161 | 0.010 |
Why?
|
| Collagen | 1 | 2010 | 2618 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2011 | 4133 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 17597 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1999 | 9237 | 0.010 |
Why?
|
| Bradycardia | 1 | 1984 | 304 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2010 | 2501 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2744 | 0.010 |
Why?
|
| Manometry | 1 | 1984 | 457 | 0.010 |
Why?
|
| Thorax | 1 | 2004 | 554 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 1729 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2011 | 2234 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 7116 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 1991 | 2627 | 0.010 |
Why?
|
| Baltimore | 1 | 2001 | 233 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 7840 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 4044 | 0.010 |
Why?
|
| Rats | 1 | 2016 | 23709 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 1997 | 881 | 0.010 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1999 | 142 | 0.010 |
Why?
|
| Cadaver | 1 | 2004 | 1362 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2689 | 0.010 |
Why?
|
| Movement | 1 | 2005 | 1461 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2009 | 3573 | 0.010 |
Why?
|
| Diuretics | 1 | 2001 | 611 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2003 | 1715 | 0.010 |
Why?
|
| Peptides | 1 | 2010 | 4338 | 0.010 |
Why?
|
| RNA, Viral | 2 | 2001 | 2868 | 0.010 |
Why?
|
| Mental Processes | 1 | 1999 | 242 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 2108 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1985 | 1169 | 0.010 |
Why?
|
| Critical Care | 1 | 2010 | 2714 | 0.010 |
Why?
|
| Infant, Premature, Diseases | 1 | 1984 | 712 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2004 | 2863 | 0.010 |
Why?
|
| Dogs | 1 | 1982 | 3825 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 1999 | 245 | 0.010 |
Why?
|
| Atrial Function, Right | 1 | 1997 | 32 | 0.010 |
Why?
|
| Equipment Design | 2 | 1997 | 3488 | 0.010 |
Why?
|
| Ecchymosis | 1 | 1997 | 32 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2271 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2006 | 2392 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2004 | 1935 | 0.010 |
Why?
|
| Calcium | 1 | 2010 | 5770 | 0.010 |
Why?
|
| Embolism, Air | 1 | 1997 | 111 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 2001 | 785 | 0.010 |
Why?
|
| Smoking | 1 | 2013 | 9076 | 0.010 |
Why?
|
| Point Mutation | 1 | 2001 | 1591 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2005 | 2121 | 0.010 |
Why?
|
| Atrial Flutter | 1 | 1997 | 253 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 6492 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2004 | 2324 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1999 | 1002 | 0.010 |
Why?
|
| Cineangiography | 1 | 1993 | 108 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1997 | 1263 | 0.010 |
Why?
|
| Equipment Safety | 1 | 1995 | 250 | 0.010 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 1994 | 185 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 2000 | 1337 | 0.010 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1993 | 122 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2009 | 3417 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 16039 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 81821 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2010 | 5365 | 0.010 |
Why?
|
| Decision Making | 1 | 2006 | 3954 | 0.010 |
Why?
|
| Wheelchairs | 1 | 1992 | 78 | 0.010 |
Why?
|
| Proteins | 1 | 2006 | 5994 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4960 | 0.010 |
Why?
|
| Cicatrix | 1 | 1997 | 797 | 0.010 |
Why?
|
| Microcirculation | 1 | 1994 | 1282 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1992 | 593 | 0.010 |
Why?
|
| Autoradiography | 1 | 1990 | 723 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 1304 | 0.000 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1994 | 1143 | 0.000 |
Why?
|
| Intraoperative Care | 1 | 1992 | 768 | 0.000 |
Why?
|
| Angiography | 1 | 1993 | 1589 | 0.000 |
Why?
|
| Capillaries | 1 | 1991 | 750 | 0.000 |
Why?
|
| False Negative Reactions | 1 | 1988 | 570 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2006 | 12128 | 0.000 |
Why?
|
| Thermodilution | 1 | 1986 | 50 | 0.000 |
Why?
|
| Wound Healing | 1 | 1997 | 2794 | 0.000 |
Why?
|
| Vena Cava, Inferior | 1 | 1988 | 463 | 0.000 |
Why?
|
| Calcinosis | 1 | 1994 | 1475 | 0.000 |
Why?
|
| False Positive Reactions | 1 | 1988 | 956 | 0.000 |
Why?
|
| Pediatric Nursing | 1 | 1986 | 104 | 0.000 |
Why?
|
| Fibroblast Growth Factors | 1 | 1991 | 871 | 0.000 |
Why?
|
| Computers | 1 | 1986 | 588 | 0.000 |
Why?
|
| Injections, Subcutaneous | 1 | 1985 | 683 | 0.000 |
Why?
|
| Aspartate Aminotransferases | 1 | 1985 | 416 | 0.000 |
Why?
|
| Swine | 1 | 1993 | 5986 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1990 | 2200 | 0.000 |
Why?
|
| Anesthesia | 1 | 1992 | 1595 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1991 | 4555 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1993 | 12772 | 0.000 |
Why?
|
| Patient Compliance | 1 | 1985 | 2694 | 0.000 |
Why?
|